Key facts
- It has raised $500K; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include gBETA, United States Department of Agriculture, State of Vermont.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Burlington Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Burlington Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Burlington Bio
Operator of a materials science and engineering company intended to offer nutrient-based food to food manufacturers. The company offers technology to enhance protein bars, supplements, and everyday staples such as crackers and pasta, and provides a meat system to clients, enabling businesses to produce nutritious food and enhance their business operations.
- Sector
- Materials and Resources
- HQ
- Burlington, VT, United States
- Founded
- 2022
- Employees
- 7
- Website
- burlington.bio/
- Ownership
- Privately Held (backing)
Burlington Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Burlington Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Burlington Bio in its N-PORT filings yet. We sweep new filings monthly.